Table 3.

Samples with both cytology results and surgical pathology results.

Alteration types		Total (n = 140)	Surgical pathology
			II (n = 1)	III (n = 12)	IV (n= 12)	V (n = 82)	VI (n= 33)	Malignant (n = 133)	Benign (n = 7)
Single nucleotide/insertion/deletion variation	BRAF V600E	89 (63.6%)	0	5	5	56	23	88	1
	BRAF V600_K601delinsE	1 (0.7%)	0	0	0	1	0	1	0
	BRAF K601_W604del	1 (0.7%)	0	0	0	1	0	1	0
	BRAF V600E/PIK3CA H1047R	1 (0.7%)	0	0	0	0	1	1	0
	BRAF V600E/PIK3CA H1047Y	1 (0.7%)	0	0	0	0	1	1	0
	BRAF V600E/RET N783S	1 (0.7%)	0	0	0	1	0	1	0
	BRAF V600E/TERT C228T	1 (0.7%)	0	0	0	0	1	1	0
	BRAF V600E/TP53 R248Q	1 (0.7%)	0	0	0	0	1	1	0
	AKT1 E17K	1 (0.7%)	0	0	0	1	0	1	0
	HRAS Q61R	1 (0.7%)	0	0	0	1	0	1	0
	KRAS Q61K	3 (2.1%)	0	1	0	2	0	3	0
	NRAS Q61R	2 (1.4%)	0	1	0	1	0	2	0
	NRAS Q61R/TERT C228T	1 (0.7%)	0	0	1	0	0	1	0
	PTEN I135Mfs*44/PTEN C124F	1 (0.7%)	1	0	0	0	0	0	1
	PTEN L140Ffs*6/PTEN R173P	1 (0.7%)	0	0	0	0	1	1	0
	PTEN N262Qfs*35	1 (0.7%)	0	1	0	0	0	0	1
	PTEN R130Q	1 (0.7%)	0	0	0	1	0	1	0
	PTEN R335*/TSHR L629F	1 (0.7%)	0	1	0	0	0	1	0
	RET M918T	1 (0.7%)	0	0	0	1	0	1	0
	TERT C228T	1 (0.7%)	0	1	0	0	0	1	0
Gene fusion	CCDC6(1)-RET(12)	2 (1.4%)	0	0	0	1	1	2	0
	NCOA4(8)-RET(12)	3 (2.1%)	0	0	1	2	0	3	0
	ETV6(4)-NTRK3(14)	1 (0.7%)	0	0	0	0	1	1	0
Negative		23	0	2	5	13	3	19	4

No distinction in sample types (FNAB samples or FFPE samples).